The supply of medicines in Europe is in danger

Alexander Krujatz, chief commercial officer, Centrient Pharmaceuticals, explains the decreasing resilience of the supply chain of essential drugs to European patients, and what can be done to safeguard the essential medicines for patients in Europe.